Pinnacle Financial Group, Inc.’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1K Buy
+600
New +$8.97K ﹤0.01% 1585

Other funds holding SMMT

Pinnacle Financial Group, Inc.'s SMMT Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 600 shares worth $10.1K. The stake represents ﹤0.01% of the portfolio and ranks #1585 among its holdings.

295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 600 shares of Summit Therapeutics worth $10.1K as of Q3 2026.
  • Summit Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Summit Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1585 holding.
  • 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.